What does CFFTI stand for?

Cystic Fibrosis Foundation Therapeutics, Inc. (est. 2000)

This definition appears very rarely and is found in the following Acronym Finder categories:

Organizations, NGOs, schools, universities, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Consortium for Fossil Fuel Science (University of Kentucky) Charity Foundation for Special Diseases Canadian Forces Fleet School Esquimalt Call for Fire Trainer (software) Central Florida Floor Tech, Inc (Florida) Chronic Feto-Fetal Transfusion (neonatal morbidity) Civitavecchia Fruit & Forest Terminal (Italy) Compagnie Folklorique Fanny Thibout (Belgian dancing and arts group) Complex Fast Fourier Transform Cystic Fibrosis Foundation Therapeutics, Inc. (Cystic Fibrosis Foundation)		Canadian Forces Flying Training School (Canada) California Fly Fishers Unlimited Chicago Fire Fighters Union Clean Fuel Fleet Vehicle Combination Form Factor Vertical (ethernet expansion card) Community Foundation for the Fox Valley Region (Wisconsin) Call for Fire Zone Carl-Friedrich-Gauss Schule (German school, Hemmingen, lower Saxony) Centerfold Girl Centrex Feature Gateway (Lucent)

Samples in periodicals archive:

Alnara's lead product is liprotamase, a novel, non-porcine pancreatic enzyme replacement therapy, which has completed Phase 3 clinical development in collaboration with the Cystic Fibrosis Foundation Therapeutics, Inc.

Alnara Pharmaceuticals' Liprotamase Demonstrates Long-Term Safety & ...

Throughout the development of denufosol, Inspire has worked closely with the Cystic Fibrosis Foundation (CFF) and its Therapeutics Development Network (TDN), a nationwide network of nearly 80 CF clinical research centers, and the Cystic Fibrosis Foundation Therapeutics, Inc.

Inspire Announces Presentation at the North American Cystic Fibrosis ...

Liprotamase is being developed in collaboration with the Cystic Fibrosis Foundation Therapeutics, Inc.

Long-Term Data from Landmark Phase 3 Safety and Nutritional Study ...

VX-770 was advanced into preclinical development and subsequent clinical trials based on a collaborative research program with Cystic Fibrosis Foundation Therapeutics, Inc.

Vertex Announces Positive 28-Day Results for VX-770, an Oral ...

NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it has achieved another milestone in its collaboration with Cystic Fibrosis Foundation Therapeutics, Inc.

EPIX Pharmaceuticals Achieves Milestone from Collaboration with ...

NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it has expanded its collaboration with Cystic Fibrosis Foundation Therapeutics, Inc.

EPIX Pharmaceuticals Expands Collaboration with Cystic Fibrosis ...

25 million milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc.

EPIX Pharmaceuticals Achieves $1.25 Million Milestone in ...

announced today that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc.

Copernicus Receives Milestone Payment from Cystic Fibrosis Foundation ...